Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Journal of Medicinal Chemistry
|
February 26, 2016
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Laetitia J Martin, Manfred Koegl, Gerd Bader, et al.
Journal of Medicinal Chemistry
|
October 27, 2022
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS<sup>G12C</sup> Inhibitor
Joachim Bröker, Alex G Waterson, Chris Smethurst, et al.
Journal of Medicinal Chemistry
|
March 15, 2021
One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS
Juergen Ramharter, Dirk Kessler, Peter Ettmayer, et al.
Cancer Discovery
|
August 21, 2020
BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition
Marco H Hofmann, Michael Gmachl, Juergen Ramharter, et al.
Journal of Medicinal Chemistry
|
August 1, 2019
Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor <b>BI-4924</b> Disrupts Serine Biosynthesis
Harald Weinstabl, Matthias Treu, Joerg Rinnenthal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 24, 2019
Drugging an undruggable pocket on KRAS
Dirk Kessler, Michael Gmachl, Andreas Mantoulidis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2020
Reply to Tran et al.: Dimeric KRAS protein-protein interaction stabilizers
Dirk Kessler, Andreas Gollner, Michael Gmachl, et al.
Cell Reports
|
September 21, 2017
Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6
Nina Kerres, Steffen Steurer, Stefanie Schlager, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Journal of Medicinal Chemistry
|
February 26, 2016
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
Laetitia J Martin, Manfred Koegl, Gerd Bader, et al.
Journal of Medicinal Chemistry
|
October 27, 2022
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS<sup>G12C</sup> Inhibitor
Joachim Bröker, Alex G Waterson, Chris Smethurst, et al.
Journal of Medicinal Chemistry
|
March 15, 2021
One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS
Juergen Ramharter, Dirk Kessler, Peter Ettmayer, et al.
Cancer Discovery
|
August 21, 2020
BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition
Marco H Hofmann, Michael Gmachl, Juergen Ramharter, et al.
Journal of Medicinal Chemistry
|
August 1, 2019
Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor <b>BI-4924</b> Disrupts Serine Biosynthesis
Harald Weinstabl, Matthias Treu, Joerg Rinnenthal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 24, 2019
Drugging an undruggable pocket on KRAS
Dirk Kessler, Michael Gmachl, Andreas Mantoulidis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 13, 2020
Reply to Tran et al.: Dimeric KRAS protein-protein interaction stabilizers
Dirk Kessler, Andreas Gollner, Michael Gmachl, et al.
Cell Reports
|
September 21, 2017
Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6
Nina Kerres, Steffen Steurer, Stefanie Schlager, et al.
Page
of 3